The current stock price of 9VC.DE is 3.426 EUR. In the past month the price increased by 6.93%. In the past year, price increased by 163.44%.

9VC.DE Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to 9VC.DE. When comparing the yearly performance of all stocks, 9VC.DE is one of the better performing stocks in the market, outperforming 96.95% of all stocks.

Chartmill TA Rating

Chartmill Setup Rating

9VC.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to 9VC.DE. No worries on liquidiy or solvency for 9VC.DE as it has an excellent financial health rating, but there are worries on the profitability.

Chartmill FA Analysis

Valuation

Growth

Profitability

Health

Dividend

9VC.DE Financial Highlights

Over the last trailing twelve months 9VC.DE reported a non-GAAP Earnings per Share(EPS) of -0.7.

		Industry Rank	Sector Rank
PM (TTM)	N/A
ROA	-62.24%
ROE	-93.44%
Debt/Equity	0

Chartmill High Growth Momentum

EPS Q2Q%-75%

Sales Q2Q%1772.5%

EPS 1Y (TTM)0%

Revenue 1Y (TTM)-1.91%

9VC.DE Forecast & Estimates

18 analysts have analysed 9VC.DE and the average price target is 10.49 EUR. This implies a price increase of 206.11% is expected in the next year compared to the current price of 3.426.

For the next year, analysts expect an EPS growth of 30.67% and a revenue growth 468.25% for 9VC.DE

Analysts

Analysts83.33

Price Target10.49 (206.19%)

EPS Next Y30.67%

Revenue Next Year468.25%

9VC.DE Ownership

Ownership

Inst Owners12.45%

Ins Owners3.7%

Short Float %N/A

Short RatioN/A

About 9VC.DE

Company Profile

9VC logo image ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. The company is headquartered in Amstelveen, Noord-Holland and currently employs 54 full-time employees. The company went IPO on 2021-06-18. The firm focused on developing treatments for mental health disorders. The firm's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.

Company Info

ATAIBECKLEY INC

Prof. J.H.Bavincklaan 7

Amstelveen NOORD-HOLLAND NL

Employees: 54

9VC Company Website

9VC Investor Relations

Phone: 31207932536

ATAIBECKLEY INC / 9VC.DE FAQ

What does ATAIBECKLEY INC do?

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. The company is headquartered in Amstelveen, Noord-Holland and currently employs 54 full-time employees. The company went IPO on 2021-06-18. The firm focused on developing treatments for mental health disorders. The firm's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.

What is the current price of 9VC stock?

The current stock price of 9VC.DE is 3.426 EUR. The price decreased by -1.21% in the last trading session.

Does 9VC stock pay dividends?

9VC.DE does not pay a dividend.

What is the ChartMill technical and fundamental rating of 9VC stock?

9VC.DE has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.

How is the valuation of ATAIBECKLEY INC (9VC.DE) based on its PE ratio?

ATAIBECKLEY INC (9VC.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.7).